ClinicalTrials.Veeva

Menu

Application of AI in Polypectomy

Y

Yanqing Li

Status

Unknown

Conditions

Colonic Polyp

Treatments

Other: AI system

Study type

Interventional

Funder types

Other

Identifiers

NCT04485715
2020SDU-QILU-0714

Details and patient eligibility

About

The aim of this study was to assess the performance of AI system in polypectomy

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • to undergo colorectal polypectomy;
  • agree to give written informed consent

Exclusion criteria

  • patients with the contraindications to colorectal polypectomy;
  • patients with a history of inflammatory bowel disease (IBD), CRC, colorectal surgery;
  • patients with high suspicion of polyposis syndromes, IBD and typical advanced CRC;
  • patients refused to participate in the trial;
  • the procedure cannot be completed due to stenosis, obstruction, huge occupying lesions, or solid stool;
  • the procedure have to be terminated due to complications of anaesthesia.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

1,000 participants in 2 patient groups

AI-aided group
Experimental group
Treatment:
Other: AI system
control group
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Yanqing Li, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems